Bliss GVS Pharma expands capital through ESOP allotment

Bliss GVS Pharma Limited announced the allotment of 66,380 equity shares of Re. 1/- face value each to eligible employees under its Employee Stock Option Plan 2019 (Bliss GVS ESOP-2019). The allotment, approved by the ESOP Allotment Committee on December 09, 2025, increases the company's total issued, subscribed, and paid-up share capital from 10,57,22,593 equity shares to 10,57,88,972 equity shares.

The newly allotted shares have an exercise price of Rs. 43/- per share, including a premium of Rs. 42/- per share. These shares are subject to a lock-in period of six months from the allotment date, expiring on June 09, 2026. All new shares will rank pari passu with the existing equity shares of the company.

The company's shares are listed on BSE Limited and the National Stock Exchange of India Limited. The details of this allotment align with Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.